Citation: Mk. Brawer et al., Long-term stability of alpha-1-antichymotrypsin complexed form of prostatespecific antigen, PROSTATE C, 3(3), 2000, pp. 191-194
Authors:
Murphy, GP
Snow, PB
Brandt, J
Elgamal, A
Brawer, MK
Citation: Gp. Murphy et al., Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint (R) scintiscans, PROSTATE, 42(2), 2000, pp. 145-149
Authors:
Catalona, WJ
Southwick, PC
Slawin, KM
Partin, AW
Brawer, MK
Flanigan, RC
Patel, A
Richie, JP
Walsh, PC
Scardino, PT
Lange, PH
Gasior, GH
Loveland, KG
Bray, KR
Citation: Wj. Catalona et al., Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging, UROLOGY, 56(2), 2000, pp. 255-260
Authors:
Catalona, WJ
Partin, AW
Slawin, KM
Naughton, CK
Brawer, MK
Flanigan, RC
Richie, JP
Patel, A
Walsh, PC
Scardino, PT
Lange, PH
deKernion, JB
Southwick, PC
Loveland, KG
Parson, RE
Gasior, GH
Citation: Wj. Catalona et al., Percentage of free PSA in black versus white men for detection and stagingof prostate cancer: A prospective multicenter clinical trial, UROLOGY, 55(3), 2000, pp. 372-376
Authors:
Brawer, MK
Cheli, CD
Neaman, IE
Goldblatt, J
Smith, C
Schwartz, MK
Bruzek, DJ
Morris, DL
Sokoll, LJ
Chan, DW
Yeung, KK
Partin, AW
Allard, WJ
Citation: Mk. Brawer et al., Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer, J UROL, 163(5), 2000, pp. 1476-1480
Citation: Mk. Brawer, 8th International Prostate Cancer Update - 28th January-1st February 1998 - Beaver Creek, Colorado, USA - Introduction, PROSTATE C, 2, 1999, pp. 1-1
Authors:
Brawer, MK
Lin, DW
Williford, WO
Jones, K
Lepor, H
Citation: Mk. Brawer et al., Effect of finasteride and or terazosin on serum PSA: Results of VA cooperative study #359, PROSTATE, 39(4), 1999, pp. 234-239
Citation: Rg. Nixon et al., Differences in prostate size between patients from university and veteransaffairs medical center populations, PROSTATE, 38(2), 1999, pp. 144-150
Authors:
Southwick, PC
Catalona, WJ
Partin, AW
Slawin, KM
Brawer, MK
Flanigan, RC
Patel, A
Richie, JP
Walsh, PC
Scardino, PT
Lange, PH
Gasior, GH
Parson, RE
Loveland, KG
Citation: Pc. Southwick et al., Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: A prospective multicenter clinical trial, J UROL, 162(4), 1999, pp. 1346-1351